Myriad Genetics CEO Purchases $199,844 of Stock as Shares Trade Near Five-Dollar Range
Myriad Genetics CEO Samraat S. Raha bought 40,000 shares on March 9, 2026, spending $199,844 at prices between $4.97 and $5.00. The transaction raises Raha's direct holdings to 493,104 shares as the company's stock trades near $4.81 after a year-long 52.75% drop. Myriad reported a fourth-quarter 2025 earnings and revenue beat, and analysts cited by…